Open — closes in 54 days

DoW Multiple Sclerosis Clinical Trial Award

JoAnn Martin Grantor

Looking for science & technology funding? JoAnn Martin Grantor is accepting applications for this award from eligible applicants, with applications due Aug 13, 2026.

Go to the Grants.gov listing
Deadline
Aug 13, 2026
Expected awards
3
Posted
May 5, 2026
Opportunity number
HT942526MSRPCTA
CFDA
12.420

Opportunity description

Summary: The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. All applications must address at least one of the FY26 MSRP CTA focus areas. Clinical trials may evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies.


Distinctive Features: The FY26 CTA offers two funding levels. The following are generalized descriptions of the scope of research appropriate for each funding level:


• Funding Level 1 (CTA-FL1) supports small-scale, proof-of-principle clinical trials (e.g., pilot, first-in-human, phase 0) to demonstrate feasibility or inform the design of more advanced trials, or other clinical trials that are appropriate for this funding level. Preliminary data relevant to the proposed clinical trial are required.


• Funding Level 2 (CTA-FL2) supports larger-scale clinical trials at phase 1 or phase 2 that seek to show preliminary evidence of safety or efficacy (i.e., benefit of clinical or paraclinical outcomes) in relevant patient populations. Clear description and justification should be provided, which could include, but is not limited to, the intervention type, trial duration, sample size, outcome measures, assessment tools and frequency of assessment. Preliminary data relevant to the proposed clinical trial in MS populations are required.


For the purposes of this funding opportunity, Regulatory Agency refers to the U.S. Food and Drug Administration (FDA) or any relevant international regulatory agency unless otherwise noted.

Who can apply

  • Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Agency contact

JoAnn Martin Grantor

eBRAP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org

help@eBRAP.org

Next steps to apply

To apply, head to the official Grants.gov listing — that is where registration and submission happen. Always re-check the closing date there, as agencies can revise it.

Official Grants.gov listing

This listing is sourced from the public Grants.gov database (U.S. government public-domain data) and is provided for general informational purposes. VolunteerBadge is not affiliated with Grants.gov or any federal agency and does not administer or award grants. Always verify details on the official listing.

Put your grant to work — with vetted volunteers.

VolunteerBadge gives funded nonprofits affordable, compliant volunteer screening — $5 a check, identity verified, done in minutes.

See how it works

Related grant opportunities